Radiation Oncology Journal

The Risk of Antihypertensive Drug among Breast Cancer Patient: A Systematic Review and Meta-analysis

Sinta Wiranata, Ida Ayu Widya Anjani, Putri Ayu Wulandari, Anak Agung Bagus Putra Indrakusuma, I Gede Krisna Arim Sadeva, Ayu Dilia Febriani Wisnawa, Jonny Karunia Fajar, I Putu Yuda Prabawa, Putu Anda Tusta Adiputra, I Wayan Sudarsa, Anak Agung Wiradewi

Open Access Macedonian Journal of Medical Sciences.2021; 9(F): 327. CrossRef

10 years of success achieved by eribulin while treating HER2-negative mBC: from randomized studies to routine practice

Tumors of female reproductive system.2021; 17(3): 59. CrossRef

Outcome-Oriented Deep Temporal Phenotyping of Disease Progression

IEEE Transactions on Biomedical Engineering.2021; 68(8): 2423. CrossRef

Prognostic value of peptidyl-prolyl cis–trans isomerase 1 (PIN1) in human malignant tumors

S. G. Khoei, C. Mohammadi, Y. Mohammadi, S. Sameri, R. Najafi

Clinical and Translational Oncology.2020; 22(7): 1067. CrossRef

Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters

Prognostic factors in metastatic breast cancer: a prospective single-centre cohort study in a Finnish University Hospital

Peeter Karihtala, Anniina Jääskeläinen, Nelli Roininen, Arja Jukkola

Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer

Shelvin K. Vadi, Bhagwant R. Mittal, Ashwani Sood, Gurpreet Singh, Amanjit Bal, Ashwin S. Parihar, Anish Bhattacharya, Rajender K. Basher, Rakesh Kapoor

Nuclear Medicine Communications.2019; 40(1): 63. CrossRef

Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer

Lou Hochheiser, John Hornberger, Michelle Turner, Gary H Lyman

Journal of Comparative Effectiveness Research.2019; 8(5): 289. CrossRef

Cancer recurrence times from a branching process model

PLOS Computational Biology.2019; 15(11): e1007423. CrossRef

Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer—A Single Institution Experience

Bianca Rogoz, Agathe Houzé de l'Aulnoit, Alain Duhamel, Denis Houzé de l'Aulnoit

Clinical Breast Cancer.2018; 18(3): 246. CrossRef

Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience

A. Houzé de l’Aulnoit, B. Rogoz, C. Pinçon, D. Houzé de l’Aulnoit

Lifetime cost-effectiveness analysis of intraoperative radiation therapy versus external beam radiation therapy for early stage breast cancer

Cost Effectiveness and Resource Allocation.2017;[Epub] CrossRef

Patterns of recurrence and treatment in male breast cancer: A clue to prognosis?

Miguel Henriques Abreu, Pedro Henriques Abreu, Noémia Afonso, Deolinda Pereira, Rui Henrique, Carlos Lopes

International Journal of Cancer.2016; 139(8): 1715. CrossRef

Optimal surveillance for postoperative metastasis in breast cancer patients

Masujiro Makita, Takehiko Sakai, Akiko Ogiya, Dai Kitagawa, Hidetomo Morizono, Yumi Miyagi, Kotaro Iijima, Takuji Iwase

Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study

Stefania Gori, Alessandro Inno, Valentina Rossi, Monica Turazza, Elena Fiorio, Alessandra Fabi, Giancarlo Bisagni, Jennifer Foglietta, Daniele Santini, Ida Pavese, Arianna Pellegrino, Alberto Zambelli, Patrizia Vici, Vita Leonardi, Sandro Barni, Silvana S

Analysis of Indoleamine 2-3 Dioxygenase (IDO) and EGFR Co-expression in Breast Cancer Tissue by Immunohistochemistry

Wei-Wei Bi, Wei-Hua Zhang, Gui-Hua Yin, Hong Luo, Shou-Qin Wang, Hongran Wang, Chao Li, Wei-Qun Yan, De-Zhi Nie

Asian Pacific Journal of Cancer Prevention.2014; 15(14): 5535. CrossRef